Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Zane Burke is the new CEO of Livongo Health, the applied health signals company announced Dec. 18. Burke previously spent five years as president of health IT company Cerner Corp. Livongo also announced that Chief Medical Officer Jennifer Schneider has been promoted to president, overseeing product, data science, software engineering, marketing, and clinical operations.
Latest From Companies
Abbott has exercised an option to buy Cephea Valve Technologies, developer of a minimally-invasive replacement heart valve, for an undisclosed sum.
GE Healthcare is making a bid to become the leader in precision medicine by collaborating with Vanderbilt University Medical Center to develop AI-powered diagnostic tools for cancer care.
Neuromodulation firm Nexstim will launch its SmartFocus TMS system for treating major depressive disorder (MDD) in Canada after signing an exclusive agreement with distributor Canada Health Solutions CHS.
In this edition of Device Week, Medtech Insight's Catherine Longworth reviews the year in mergers and acquisitions, including big moves by Medtronic, Stryker and Boston Scientific. Looking forward to 2019, companies will be looking for acquisitions to help them take advantage of the emergence of Asia as the second-biggest device market, respond to Brexit, and potentially cope with new device regulations around the world.
Johnson & Johnson has entered a strategic collaboration with genomics diagnostics company Veracyte to develop and commercialize tests for detecting lung cancer.
Boston Scientific has acquired the remaining shares of privately held mitral-valve repair device company Millipede for $325m.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.